Bml Capital Management, LLC
· Added
Change
+1.4M
Date
Q1 2026
OM
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bml Capital Management, LLC
· Added
Change
+1.4M
Date
Q1 2026
|
Bml Capital Management, LLC | Added· Q1 2026 | – | +1.4M | – | Q1 2026 | |||||
|
AQR Capital Management LLC
· Added
Change
+628K
Date
Q1 2026
|
AQR Capital Management LLC | Added· Q1 2026 | – | +628K | – | Q1 2026 | |||||
|
Stratos Wealth Partners, Ltd.
· New
Change
+201K
Date
Q1 2026
|
Stratos Wealth Partners, Ltd. | New· Q1 2026 | – | +201K | – | Q1 2026 | |||||
|
UBS Group AG
· Added
Change
+179K
Date
Q1 2026
|
UBS Group AG | Added· Q1 2026 | – | +179K | – | Q1 2026 | |||||
|
Renaissance Technologies LLC
· Added
Change
+177K
Δ Own
+391.3%
Date
Q1 2026
|
Renaissance Technologies LLC | Added· Q1 2026 | – | +177K | +391.3% | Q1 2026 | |||||
|
FMR LLC
· Added
Change
+101K
Δ Own
+3.8%
Date
Q1 2026
|
FMR LLC | Added· Q1 2026 | – | +101K | +3.8% | Q1 2026 | |||||
|
Pura Vida Investments, LLC
· Added
Change
+78K
Date
Q1 2026
|
Pura Vida Investments, LLC | Added· Q1 2026 | – | +78K | – | Q1 2026 | |||||
|
Pfm Health Sciences, LP
· Added
Change
+64K
Date
Q1 2026
|
Pfm Health Sciences, LP | Added· Q1 2026 | – | +64K | – | Q1 2026 | |||||
|
Xtx Topco Ltd
· Added
Change
+42K
Date
Q1 2026
|
Xtx Topco Ltd | Added· Q1 2026 | – | +42K | – | Q1 2026 | |||||
|
Ieq Capital, LLC
· New
Change
+40K
Date
Q1 2026
|
Ieq Capital, LLC | New· Q1 2026 | – | +40K | – | Q1 2026 | |||||
|
Jane Street Group, LLC
· Added
Change
+39K
Date
Q1 2026
|
Jane Street Group, LLC | Added· Q1 2026 | – | +39K | – | Q1 2026 | |||||
|
BNP Paribas Financial Markets
· Added
Change
+31K
Date
Q1 2026
|
BNP Paribas Financial Markets | Added· Q1 2026 | – | +31K | – | Q1 2026 | |||||
|
Centiva Capital, LP
· Added
Change
+31K
Date
Q1 2026
|
Centiva Capital, LP | Added· Q1 2026 | – | +31K | – | Q1 2026 | |||||
|
Morgan Stanley
· Added
Change
+30K
Date
Q1 2026
|
Morgan Stanley | Added· Q1 2026 | – | +30K | – | Q1 2026 | |||||
|
Geode
· Added
Change
+21K
Date
Q1 2026
|
Geode | Added· Q1 2026 | – | +21K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Brottem John L.
· Officer
Grant (A)
60K
|
Brottem John L. | Officer | Grant (A) | – | 60K | – | 90K | +197.6% | Jun 26, 2026 | Jun 29, 2026 | |||||||||
|
Gaeta Renee
· Officer
Grant (A)
72K
|
Gaeta Renee | Officer | Grant (A) | – | 72K | – | 185K | +63.0% | Jun 26, 2026 | Jun 29, 2026 | |||||||||
|
Trigg Leslie
· Director
Grant (A)
99K
|
Trigg Leslie | Director | Grant (A) | – | 99K | – | 198K | +100.3% | Jun 26, 2026 | Jun 29, 2026 | |||||||||
|
Hackett Patrick T.
· Director
Grant (A)
11K
|
Hackett Patrick T. | Director | Grant (A) | – | 11K | – | 106K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Oboyle Kevin C.
· Director
Grant (A)
11K
|
Oboyle Kevin C. | Director | Grant (A) | – | 11K | – | 35K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Prange Karen
· Director
Grant (A)
11K
|
Prange Karen | Director | Grant (A) | – | 11K | – | 29K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Lang Brent D.
· Director
Grant (A)
11K
|
Lang Brent D. | Director | Grant (A) | – | 11K | – | 29K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Grossman D. Keith
· Director
Grant (A)
11K
|
Grossman D. Keith | Director | Grant (A) | – | 11K | – | 25K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Drexler Karen
· Director
Grant (A)
11K
|
Drexler Karen | Director | Grant (A) | – | 11K | – | 21K | – | Jun 4, 2026 | Jun 5, 2026 | |||||||||
|
Gaeta Renee
· CFO
Sell
−$87K
|
Gaeta Renee | CFO | Sell | $4.94 | −18K | −$87K | 114K | – | Jun 3, 2026 | Jun 5, 2026 | |||||||||
|
Trigg Leslie
· Director
Sell
−$13K
|
Trigg Leslie | Director | Sell | $3.70 | −3K | −$13K | 99K | – | May 15, 2026 | May 19, 2026 | |||||||||
|
Nash Marc
· Officer
Sell
−$6K
|
Nash Marc | Officer | Sell | $3.70 | −2K | −$6K | 38K | – | May 15, 2026 | May 19, 2026 | |||||||||
|
Brottem John L.
· Officer
Sell
−$10K
|
Brottem John L. | Officer | Sell | $3.70 | −3K | −$10K | 30K | – | May 15, 2026 | May 19, 2026 | |||||||||
|
Leonard Braden Michael
· 10% Owner
Exercise or conversion (M/X/C)
$1.6M
|
Leonard Braden Michael | 10% Owner | Exercise or conversion (M/X/C) | $5.00 | 323K | $1.6M | 2.5M | – | May 15, 2026 | May 18, 2026 | |||||||||
|
Leonard Braden Michael
· 10% Owner
Exercise or conversion (M/X/C)
$484K
|
Leonard Braden Michael | 10% Owner | Exercise or conversion (M/X/C) | $5.00 | 97K | $484K | 2.2M | – | May 11, 2026 | May 12, 2026 | |||||||||
U
P
A
K
M
V
103 reporting institutions disclosed OM position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.